Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Archives of Neurology

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.64.7.998PMID 17620490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

  2006cited by this paper
• Early‐onset familial parkinsonism due to POLG mutations

  2006cited by this paper
• High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

  2006cited by this paper
• Etiology of Parkinson’s disease

  2006cited by this paper
• Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism

  2005cited by this paper
• A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism.

  2004cited by this paper
• A Novel Polymerase γ Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism

  2004cited by this paper
• Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

  2004cited by this paper
• Digenic progressive external ophthalmoplegia in a sporadic patient: Recessive mutations in POLG and C10orf2/Twinkle

  2003cited by this paper
• Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria

  2001cited by this paper
• Etiology of Parkinson's Disease

  1999cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989influential reference
• Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

  1986cited by this paper

• Wenn die Augen stillstehen

  2025cites this paper
• Mitochondrial DNA Replication and Disease: A Historical Perspective on Molecular Insights and Therapeutic Advances

  2025cites this paper
• Mitochondrial Parkinsonism: A Practical Guide to Genes and Clinical Diagnosis

  2024cites this paper
• Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease.

  2023cites this paper
• Complex neurological and multisystem presentations in mitochondrial disease.

  2023cites this paper
• Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity

  2023cites this paper
• Novel and recurrent nuclear gene variations in a cohort of Chinese progressive external ophthalmoplegia patients with multiple mtDNA deletions

  2022cites this paper
• Molecular Genetics Overview of Primary Mitochondrial Myopathies

  2022cites this paper
• Structural and dynamic basis of DNA capture and translocation by mitochondrial Twinkle helicase

  2022cites this paper
• Targeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease

  2022cites this paper
• TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective Study

  2022cites this paper
• A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson’s disease by highlighting the use of cybrid models

  2022cites this paper
• How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques

  2022cites this paper
• Mitochondrial DNA Homeostasis Impairment and Dopaminergic Dysfunction: A Trembling Balance.

  2022cites this paper
• Clinical overview and phenomenology of movement disorders

  2021cites this paper
• Parkinsonism and ataxia.

  2021cites this paper
• A Practical Approach to Early-Onset Parkinsonism

  2021cites this paper
• The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease

  2021cites this paper
• Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus

  2021cites this paper
• Movement Disorders in Children with a Mitochondrial Disease: A Cross-Sectional Survey from the Nationwide Italian Collaborative Network of Mitochondrial Diseases

  2021cites this paper
• Parkinson-related neuropathy

  2021cites this paper
• Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk

  2021cites this paper
• The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease

  2020cites this paper
• Spectrum of movement disorders in mitochondrial diseases

  2020cites this paper
• Twinkle-associated familial parkinsonism with Lewy pathology

  2020cites this paper
• Damage in Mitochondrial DNA Associated with Parkinson's Disease

  2020influential citation
• Muscle Biopsy: A Boon for Diagnosis of Mitochondrial Parkinsonism in Developing Countries

  2019cites this paper
• Diagnosis and Management of Mitochondrial Disorders

  2019cites this paper
• Mitochondrial Depletion Syndromes

  2019cites this paper
• Mitochondrial Neurodegenerative Disorders I: Parkinsonism and Cognitive Deficits

  2019cites this paper
• Mitochondrial Myopathies and Related Diseases

  2018cites this paper
• Movement disorders in mitochondrial disease: a clinicopathological correlation

  2018cites this paper
• Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance

  2018cites this paper
• Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum

  2018cites this paper
• Mitochondrial diseases: the contribution of organelle stress responses to pathology

  2017cites this paper
• Identifying new genes in mitochondrial disease

  2017influential citation
• Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

  2017cites this paper
• Characterization of Vesicular Monoamine Transporter 2 and its role in Parkinson's Disease Pathogenesis using Drosophila

  2016cites this paper
• Movement disorders in mitochondrial diseases.

  2016cites this paper
• POLG2 deficiency causes adult‐onset syndromic sensory neuropathy, ataxia and parkinsonism

  2016cites this paper
• Mutation in TWINKLE in a Large Iranian Family with Progressive External Ophthalmoplegia, Myopathy, Dysphagia and Dysphonia, and Behavior Change.

  2016cites this paper
• Novel mutation in C10orf2 associated with multiple mtDNA deletions, chronic progressive external ophthalmoplegia and premature aging.

  2016cites this paper
• Syndromic parkinsonism and dementia associated with OPA 1 missense mutations

  2015cites this paper
• A53T Human α-Synuclein Overexpression in Transgenic Mice Induces Pervasive Mitochondria Macroautophagy Defects Preceding Dopamine Neuron Degeneration

  2015cites this paper
• Genes and Pathways Involved in Adult Onset Disorders Featuring Muscle Mitochondrial DNA Instability

  2015cites this paper
• Parkinsonism in a patient with Leber hereditary optic neuropathy (LHON).

  2015cites this paper
• Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum

  2014cites this paper
• Parkinson Disease Genetics: A "Continuum" from Mendelian to Multifactorial Inheritance.

  2014cites this paper
• 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson’s disease: respirometric, histological, and behavioral analyses

  2014cites this paper
• An overview of neurological and neuromuscular signs in mitochondrial diseases.

  2014cites this paper
• Integrated pathways of parkin control over mitochondrial maintenance - relevance to Parkinson's disease pathogenesis.

  2013cites this paper
• Disorders of mitochondrial DNA polymerase: a clinical, biochemical and structural study

  2013cites this paper
• Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: a case report and an update on the state of art.

  2013cites this paper
• Mitochondrial DNA multiple deletion syndromes, autosomal dominant and recessive (POLG, POLG2, TWINKLE and ANT1)

  2013cites this paper
• The Impact of Mitochondrial DNA and Nuclear Genes Related to Mitochondrial Functioning on the Risk of Parkinson’s Disease

  2013cites this paper
• Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.

  2013cites this paper
• Mitochondrial deficiency in Cockayne syndrome.

  2013cites this paper
• Novel polymerase gamma (POLG1) gene mutation in the linker domain associated with parkinsonism

  2013cites this paper
• Autosomal dominant mutations in POLG and C10orf2: association with late onset chronic progressive external ophthalmoplegia and Parkinsonism in two patients

  2013cites this paper
• Orthostatic tremor, progressive external ophthalmoplegia, and Twinkle.

  2013cites this paper
• Identification of a novel Twinkle mutation in a family with infantile onset spinocerebellar ataxia by whole exome sequencing.

  2012cites this paper
• POLG and PEO1 (Twinkle) mutations are infrequent in PSP-like atypical parkinsonism: a preliminary screening study

  2012cites this paper
• Physical and functional interaction between yeast Pif1 helicase and Rim1 single-stranded DNA binding protein

  2012cites this paper
• Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.

  2012cites this paper
• Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism.

  2012cites this paper
• POLG1-Related and other “Mitochondrial Parkinsonisms”: an Overview

  2011cites this paper
• Compound mutations of PEO1 and TYMP in a progressive external ophthalmoplegia patient with incomplete mitochondrial neurogastrointestinal encephalomyopathy phenotype

  2011cites this paper
• Chapter 1 – Clinical overview and phenomenology of movement disorders

  2011cites this paper
• Regulation of PINK1-Parkin-mediated mitophagy

  2011cites this paper
• Movement disorders and mitochondrial disease.

  2011cites this paper
• TWINKLE gene mutation: report of a French family with an autosomal dominant progressive external ophthalmoplegia and literature review

  2011influential citation
• OXPHOS toxicogenomics and Parkinson's disease.

  2011cites this paper
• Parkinson's syndrome and Parkinson's disease in mitochondrial disorders

  2011cites this paper
• Milestones in atypical and secondary Parkinsonisms

  2011cites this paper
• Genetic analysis of two Japanese families with progressive external ophthalmoplegia and parkinsonism

  2011cites this paper
• Clinical phenotype of autosomal dominant progressive external ophthalmoplegia in a family with a novel mutation in the C10orf2 gene

  2010cites this paper
• Disease Variants of the Human Mitochondrial DNA Helicase Encoded by C10orf2 Differentially Alter Protein Stability, Nucleotide Hydrolysis, and Helicase Activity*♦

  2010cites this paper
• Inventory control: cytochrome c oxidase assembly regulates mitochondrial translation

  2010cites this paper
• The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO

  2010cites this paper
• PINK 1 Is Selectively Stabilized on Impaired Mitochondria to Activate

  2010cites this paper
• A novel variation in the Twinkle linker region causing late-onset dementia

  2010cites this paper
• Polymerase Gamma 1 Mutations: Clinical Correlations

  2010cites this paper
• PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin

  2010cites this paper
• Instabilité du génome mitochondrial et pathologies associées

  2010cites this paper
• [Mitochondrial genome instability and associated diseases].

  2010cites this paper
• Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells

  2010cites this paper
• Mechanisms of mitophagy

  2010cites this paper
• [Colorectal cancer 2D-proteomics: identification of altered protein expression].

  2009cites this paper
• Qigong for movement disorders: A systematic review

  2009cites this paper
• Association of the POLG1 T(−365)C, ANT1 G(−25)A, and PEO1 G(−605)T polymorphisms with diabetic polyneuropathy in patients with Type 1 diabetes mellitus

  2009cites this paper
• Cell Death Pathways in Parkinson's Disease: Role of Mitochondria

  2009cites this paper
• Finding twinkle in the eyes of a 71‐year‐old lady: A case report and review of the genotypic and phenotypic spectrum of TWINKLE‐related dominant disease

  2009influential citation
• Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies.

  2009cites this paper
• Extrapyramidal reaction to ondansetron and propofol

  2009cites this paper
• Neurodegenerative parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation

  2009cites this paper
• Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson’s disease risk in a Polish PD cohort

  2008cites this paper
• A novel Twinkle (PEO1) gene mutation in a Chinese family with adPEO

  2008cites this paper
• Movement disorders and inborn errors of metabolism in adults: A diagnostic approach

  2008cites this paper
• Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia

  2008cites this paper
• Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism.

  2008cites this paper